共 90 条
[1]
Escudier B(2007)Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial Lancet 370 2103-2111
[2]
Pluzanska A(2007)Sorafenib in advanced clear-cell renal-cell carcinoma N Engl J Med 356 125-134
[3]
Koralewski P(2008)Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial Lancet 372 449-456
[4]
Escudier B(2011)Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial Lancet 378 1931-1939
[5]
Eisen T(2008)Bevacizumab plus interferon alfa compared with interferon alfa monotherapy in patients with metastatic renal cell carcinoma: CALGB 90206 J Clin Oncol 26 5422-5428
[6]
Stadler WM(2007)Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma N Engl J Med 356 2271-2281
[7]
Motzer RJ(2010)Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial J Clin Oncol 28 1061-1068
[8]
Escudier B(2007)Sunitinib versus interferon alfa in metastatic renal-cell carcinoma N Engl J Med 356 115-124
[9]
Oudard S(2010)Prognosis of Japanese metastatic renal cell carcinoma patients in the cytokine era: a cooperative group report of 1463 patients Eur Urol 57 317-325
[10]
Rini BI(2012)A new prognostic classification for overall survival in Asian patients with previously untreated metastatic renal cell carcinoma Cancer Sci 103 1695-1700